🔺 What to do when markets are at an all-time high? Find smart bargains, like these.See Undervalued Stocks

Pre-Open Stock Movers 04/29: Zymeworks Gain on Takeover Chatter; Amazon, Robinhood, Intel Fall Post Earnings (more...)

Published 04/29/2022, 05:02 AM
Updated 04/29/2022, 09:04 AM
INTC
-
AAPL
-
AMZN
-
WU
-
NATI
-
MHK
-
FBIN
-
SFM
-
FIVN
-
TEAM
-
ZYME
-
VERO
-
ACCD
-
FNCH
-
HOOD
-
DJT
-

Pre-Open Stock Movers:

Finch Therapeutics Group (NASDAQ:FNCH70% HIGHER; announced that the FDA has removed the clinical hold on Finch's investigational new drug (IND) application for CP101.

Zymeworks (NYSE:ZYME) 44% HIGHER; approached by All Blue Capital about a takeover at $10.50 per share, Reuters reported

Accolade (NASDAQ:ACCD42% LOWER; reported Q4 EPS of ($0.51), $0.15 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $93.8 million versus the consensus estimate of $91.57 million. Accolade sees FY2023 revenue of $350 million - 365 million.

Mohawk Industries (NYSE:MHK) 13% HIGHER; reported Q1 EPS of $3.78, $0.88 better than the analyst estimate of $2.90. Revenue for the quarter came in at $3 billion versus the consensus estimate of $2.85 billion. Mohawk Industries sees Q2 2022 EPS of $4.25-$4.35, versus the consensus of $3.75.

Digital World Acquisition Corp (NASDAQ:DWAC12% HIGHER; former President Trump truths "I'm Back!" with the hashtag #COVFEFE on his new Truth Social Network.

Venus Concept Inc (NASDAQ:VERO) 14% LOWER; received a 510(K) clearance from the U.S. Food and Drug Administration (FDA) to market the Venus BlissMAX device (BlissMAX) with an expanded indication for use in new areas of the body and an increase in RF energy output.

Robinhood (NASDAQ:HOOD) 11% LOWER; reported Q1 EPS of ($0.45), $0.09 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $299 million versus the consensus estimate of $355.78 million.

Amazon (NASDAQ:AMZN) 10% LOWER; reported Q1 loss per share of $7.56, worse than the analyst estimate of a profit of $8.36. Revenue for the quarter came in at $116.4 billion versus the consensus estimate of $116.3 billion. Amazon sees Q2 2022 revenue of $116-121 billion, versus the consensus of $125.55 billion.

National Instruments (NASDAQ:NATI10% LOWER; reported Q1 EPS of $0.41, $0.19 better than the analyst estimate of $0.22. Revenue for the quarter came in at $385 million versus the consensus estimate of $402.72 million. NI sees Q2 2022 EPS of $0.25-$0.39, versus the consensus of $0.31. NI sees Q2 2022 revenue of $370-410 million, versus the consensus of $421.7 million.

Fortune Brands Home & Security, Inc. (NYSE:FBHS8% HIGHER; intends to separate into two publicly traded companies and also reported first-quarter 2022 results. The company will pursue a tax-free spin-off of its Cabinets business into a standalone publicly-traded company.

Western Union (NYSE:WU) 8% LOWER; reported Q1 EPS of $0.51, $0.08 better than the analyst estimate of $0.43. Revenue for the quarter came in at $1.16 billion versus the consensus estimate of $1.16 billion. Western Union sees FY2022 EPS of $1.75-$1.85, versus the consensus of $1.93.

Five9 (NASDAQ:FIVN) 6% HIGHER; reported Q1 EPS of $0.22, $0.09 better than the analyst estimate of $0.13. Revenue for the quarter came in at $182.8 million versus the consensus estimate of $170.99 million. Five9 sees Q2 2022 EPS of $0.17-$0.19, versus the consensus of $0.15. Five9 sees Q2 2022 revenue of $179-180 million, versus the consensus of $174 million. Five9 sees FY2022 EPS of $1.22-$1.24, versus the consensus of $1.13. Five9 sees FY2022 revenue of $770-773 million, versus the consensus of $756.7 million

Atlassian (NASDAQ:TEAM) 6% LOWER; reported Q3 EPS of $0.47, $0.15 better than the analyst estimate of $0.32. Revenue for the quarter came in at $740 million versus the consensus estimate of $700.72 million. Atlassian sees Q4 2022 EPS of $0.24, versus the consensus of $0.30. Atlassian sees Q4 2022 revenue of $710-725 million, versus the consensus of $710 million.

Sprouts Farmers Market (NASDAQ:SFM) 5% HIGHER; BofA Securities upgraded from Underperform to Buy with a price target of $40.

Intel (NASDAQ:INTC) 5% LOWER; reported Q1 EPS of $0.87, $0.07 better than the analyst estimate of $0.80. Revenue for the quarter came in at $18.4 billion versus the consensus estimate of $18.31 billion. Intel sees Q2 2022 EPS of $0.70, versus the consensus of $0.83. Intel sees Q2 2022 revenue of $18 billion, versus the consensus of $18.38 billion. The company sees FY2022 EPS of $3.60, versus the consensus of $3.50. INTC sees FY2022 revenue of $76 billion, versus the consensus of $75.78 billion.

Apple (NASDAQ:AAPL) 1% LOWER; reported Q2 EPS of $1.52, $0.09 better than the analyst estimate of $1.43. Revenue for the quarter came in at $97.3 billion versus the consensus estimate of $93.89 billion. Apple’s board of directors has declared a cash dividend of $0.23 per share of the company’s common stock, an increase of 5%. The dividend is payable on May 12, 2022, to shareholders of record as of the close of business on May 9, 2022. The board of directors has also authorized an increase of $90 billion to the existing share repurchase program. On its call, the company said supply-chain issues would hurt sales in the third quarter by $4 billion to $8 billion.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.